Search

Your search keyword '"Senna G"' showing total 244 results

Search Constraints

Start Over You searched for: Author "Senna G" Remove constraint Author: "Senna G" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
244 results on '"Senna G"'

Search Results

1. Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study

2. Diagnosis and Management of Allergic Rhinitis in Asthmatic Children

3. Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study

4. Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy

5. Uncontrolled Asthma: Unmet Needs in the Management of Patients

6. Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry

7. New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic

11. Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials

15. A hierarchical cluster analysis of the psycological impact of the COVID-19 pandemic on Italian severe asthma patients

16. Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma

17. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

18. Clinical features associated with a doctor-diagnosis of bronchiectasis in the Severe Asthma Network in Italy (SANI) registry

20. COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety

21. Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes

24. Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

25. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper (vol 12, 100080, 2020)

26. Severe asthma: One disease and multiple definitions

27. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

28. Frequency of tiotropium bromide use and clinical features of patients with severe asthma in a real-life setting: Data from the severe asthma network in Italy (sani) registry

29. A WAO - ARIA - GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020

30. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

31. Characteristics and treatment regimens across ERS SHARP severe asthma registries

32. Minimal clinically important difference for asthma endpoints: An expert consensus report

33. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

34. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry

35. Characteristics and treatment regimens across ERS SHARP severe asthma registries

37. Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective

39. Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy

40. One repetition maximum tests for multi-joint exercise and single-joint exercise in different visual deprivation protocols

41. The role of mobile apps in allergic respiratory diseases: An italian multicentre survey report

43. Allergic rhinitis: the eligible candidate to mite immunotherapy in the real world

44. SANI-Severe Asthma Network in Italy: A way forward to monitor severe asthma

50. Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper

Catalog

Books, media, physical & digital resources